Reported companies
There are 12,956 companies represented in the Report of data about research and development tax incentive entities 2022–23. They claimed a total of $16.2 billion in R&D expenditure for the 2022–23 income year. The report also includes an additional 179 companies that made R&D claims for the 2021–22 income year after the cut-off date for inclusion in last year’s report.
Last year's Report of data about research and development tax incentive entities did not include approximately 850 companies that made R&D expenditure claims in the 2021–22 income year as they have a substituted accounting period for the 2021–22 income year beginning before 1 July 2021. This year's report includes those companies who have a substituted accounting period for the 2022–23 income year beginning before 1 July 2022.
Reported population
The Report of data about research and development tax incentive entities population includes:
- companies with an eligible expenditure greater than $20,000, and turnover of less than $20 million, who are eligible for the refundable offset
- companies with an eligible expenditure greater than $20,000, and turnover greater than $20 million, who are eligible for the non-refundable offset
- both Australian-owned and foreign-owned companies which are Australian residents for income tax purposes.
Total expenditure
Public and multinational businesses claimed the most R&D expenditure in the 2022–23 income year with a total of $8.7 billion. This was followed by privately owned and wealthy groups with $5 billion, and lastly small businesses with $2.4 billion in R&D expenditure claimed.
Business population
The business population makeup of companies in the 2022–23 transparency report is:
- 46% (6,016) small businesses (companies that are carrying on a business with an aggregated turnover of less than $10 million)
- 35% (4,507) privately owned and wealthy groups (companies and their associated subsidiaries with an annual turnover of more than $10 million that aren't public groups or foreign owned)
- 19% (2,428) public and multinational businesses (publicly listed Australian and multinational companies).
The average claim per company in each business population is:
- public and multinational businesses – $3,599,102
- privately owned and wealthy groups – $1,111,133
- small businesses – $403,232.
Not-for-profit organisations aren't included in the breakdown and analysis as only 5 claimed the R&DTI in the 2022–23 income year. This number is too small to be evaluated.
Top 10 highest claims
Table 1 below details the top 10 companies across all industries according to their R&D expenditure claims in the 2022–23 income year.
|
Company name |
Company ABN |
Total R&D expenditure ($) |
|---|---|---|
|
ATLASSIAN AUSTRALIA 1 PTY LTD |
98166799542 |
220,184,724 |
|
FORTESCUE LTD |
57002594872 |
150,753,868 |
|
COCHLEAR LIMITED |
96002618073 |
136,678,581 |
|
GOTW PTY LTD |
31000392727 |
118,126,096 (amended to 117,672,586) |
|
CSL LIMITED |
99051588348 |
111,543,007 |
|
RESMED HOLDINGS PTY LTD |
28003765133 |
106,731,383 |
|
CHEVRON AUSTRALIA HOLDINGS PTY LTD |
60098079344 |
95,768,477 |
|
LANAI (AU) 1 PTY LTD |
86652351909 |
80,945,334 |
|
RIO TINTO LIMITED |
96004458404 |
73,157,842 |
|
GRINDING MEDIA PTY LTD |
47615611759 |
68,814,589 |